Viewing StudyNCT05775159

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 6:46 PM
Last Modification Date: 2024-10-26 @ 2:54 PM
Study NCT ID: NCT05775159
Status: RECRUITING
Last Update Posted: 2024-04-12
First Post: 2023-03-02
Brief Title: Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
Sponsor: AstraZeneca
Organization: AstraZeneca
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Hepatocellular Carcinoma
Biliary Tract Cancer
Keywords:
Name View
Rilvegostomig View
Hepatobiliary cancer View
Hepatocellular carcinoma View
Biliary tract cancer View
GEMINI-Hepatobiliary View
MEDI5752 View
AZD2936 View
Bispecific antibody View
Volrustomig View